generally reporting lower obesity rates than regions with harsher climates or fewer recreational options. This chart shows the prevalence of obesity among U.S. adults in 2023, by state/territory.

Receiver operating characteristic curve, AUC, sensitivity, specificity, positive likelihood ratio and negative likelihood ratio were estimated to evaluate the accuracy of the growth references for ...

Hims stock rose early Tuesday after compounded weight-loss drugs helped build on a "robust" trajectory for Hims & Hers Health ...

Treatment options for obesity typically include lifestyle measures such as diet and exercise. However, therapy can also help by teaching you the skills needed to maintain a healthier lifestyle.

BMI is a quick and convenient tool for assessing weight-related health risks, but some researchers back replacing it with an ...

Related Text-messaging program helps parents prevent obesity in young children Ozempic ... focused on almost 15,000 adult ...

Oct. 30, 2024 — Young people with severe obesity who underwent weight-loss surgery at age 19 or younger continued to see sustained weight loss and resolution of common obesity-related ...

Pudgy pets are a problem in America. According to the Association for Pet Obesity Prevention, a shocking 56% of dogs and 60% ...

Here are the key points about Viking Therapeutics' oral obesity drug VK2735: Early-Stage Trial Results: All doses of VK2735 ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

Can-Fite BioPharma (CANF) has released an update. Can-Fite BioPharma Ltd. has received a patent allowance in Australia for ...

Viking Therapeutics (VKTX) surges on promising obesity drug results. Explore key price levels and analyst insights in this detailed analysis.